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Glucuronidation is an important phase II metabolic pathway for endogenous and 
exogenous substrates and is generally considered as a detoxification pathway, but acyl 
glucuronides (AGs) have been believed to be related with the toxicity of carboxyl acid drugs, 
because AGs covalently bind to endogenous proteins owing to their instability. However, the 
theory remains controversial. In this study, first, in vitro assays of half-lives, peptide adducts 
and immunostimulation of AGs of 21 drugs were performed, and the relationship to toxic 
categories of drugs was analyzed. Short half-lives, peptide adducts and immunostimulation 
were observed in AGs of all withdrawn drugs tested in this study. The immunostimulation 
assay showed higher sensitivity, specificity, and accuracy than half-lives and peptide adducts
assays. Second, responsibility of zomepirac acyl glucuronide (ZP-AG) for renal toxicity by
zomepirac (ZP) was investigated by in vivo studies. ZP-induced kidney injury mouse model 
was established by pretreatment with an esterase inhibitor and a glutathione synthesis 
inhibitor. It was demonstrated that ZP-AG accumulation in kidney was responsible for the 
renal toxicity. This study provides new insight into the evaluation of AG toxicity in drug 
development.
Dissertation abstract 
Glucuronidation, an important phase II metabolic pathway, is generally considered as a 
detoxification pathway, but AGs of drugs are generally unstable and are believed to be 
involved in drug-induced toxicity via the formation of covalent adducts to endogenous 
proteins. However, the toxicity of AGs remains unclear. This study had two purposes. First
purpose was to evaluate the toxicity of AGs by utilizing the in vitro assays of half-lives, 
peptide adducts and immunostimulation. ZP is one of carboxyl acid drugs withdrawn from the 
market due to adverse effects such as renal toxicity and anaphylaxis. It was demonstrated, by 
previous in vitro studies, that ZP-AG formed protein adducts, suggesting that ZP-AG was
involved in toxicity caused by ZP. However, the toxicity of ZP-AG has not been proved by in 
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vivo study. Second purpose was to investigate by in vivo study whether ZP-AG is responsible
for renal toxicity by ZP.  
In vitro toxicological evaluation of acyl glucuronides by half-lives, peptide adducts, and 
immunostimulation assays 
Chemical reactivity of AGs is believed to be involved in the toxicity of carboxylic 
acid-containing drugs. Both direct and immune-mediated toxicity have been suggested as 
possible mechanisms of toxicity; however, it remains unclear. In this study, the assays of 
half-lives, peptide adducts, and immunostimulation were performed to evaluate the potential 
risk of AGs of 21 drugs and analyzed the relationship to the toxic category. AGs of all 
withdrawn drugs tested in this study showed short half-lives and peptide adducts formation, 
but so did those of several safe drugs. In contrast, only AGs of withdrawn and warning drugs 
induced IL-8 in hPBMCs. It was found by a DNA microarray assay that zomepirac AG 
induced the mRNAs of 5 genes, including IL-8 in hPBMCs. In addition, withdrawn and 
warning drugs were distinguished from safe drugs by an integrated score of relative mRNA 
expression levels of 5 genes. The immunostimulation assay showed higher sensitivity, 
specificity, and accuracy compared with other methods. In preclinical stage in drug 
development, the evaluation of immunostimulation by AGs using hPBMCs can contribute to 
improved drug safety assessment.
In vivo toxicological evaluation of zomepirac acyl glucuronide 
Zomepirac (ZP) was withdrawn from the market because of their adverse effects such as 
renal toxicity. ZP is mainly metabolized to acyl glucuronide (ZP-AG) by UGT. However, the 
responsibility of ZP-AG to renal toxicity has never been proven. In this study, ZP-induced 
kidney injury mouse model was established by pretreatment with tri-o-tolyl phosphate 
(TOTP), a non-selective esterase inhibitor, and L-buthionine-(S,R)-sulfoximine (BSO), a 
glutathione synthesis inhibitor, and then the responsibility of ZP-AG to renal toxicity was 
investigated. Mice received only ZP showed significant increase of blood urea nitrogen 
(BUN) and creatinine (CRE) by pretreatment with TOTP and BSO, but not increase of 
alanine aminotransferase. The ZP-AG levels in plasma and liver were elevated by co-treated 
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with TOTP, and especially in kidney. The ZP-AG concentrations in kidney were correlated 
with BUN and CRE. In histopathological examination, the vacuoles and infiltration of 
mononuclear cells were observed in mouse model. In addition to immune- and 
inflammation-related responses, the oxidative stress markers such as glutathione/disulfide 
glutathione ratio and malondialdehyde (MDA) levels were changed by TOTP, BSO and 
ZP-administration. Since the ZP-induced kidney injury was suppressed by treatment with 
tempol, an antioxidant agent, the involvement of oxidative stress was suggested in the 
ZP-induced kidney injury. This is the first study to demonstrate that AG accumulation in 
kidney by TOTP and BSO-treatment was responsible for the renal toxicity and to show the in 
vivo toxicological potential of AGs.
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は、in vitro および in vivo で AG について毒性学的に評価することを目的としたもので









果は免疫活性化法の in vitro AG 毒性評価法としての有用性および in vivo レベルでの
AG の毒性への関与を示し、カルボン酸化合物の安全性評価に貢献するものであり、博士
（創薬科学）に値すると判定した。
